Type 2 & other diabetes

Assessment of basal insulin adherence in people with type 2 diabetes in telemonitoring: Post-hoc analysis of novel data modalities including insulin injection data

Diabetes Res Clin PractPublished Post-hoc analysis of telemonitoring data

Authors' conclusion

Utilizing insulin injection data our results provide detailed insights into basal insulin adherence behavior, including irregularities and daily dose adjustments. Our findings are necessary for supporting healthcare providers' preventable efforts and optimizing diabetes care.

Study context

Population
People with insulin-treated T2D in telemonitoring, using connected insulin pens
Participants
165 people
Comparison
Adherent vs non-adherent participants
Primary endpoint
Basal insulin adherence: overall adherence, adherence distribution and dose deviation
Methodological detailsconnected insulin pen injection data
  • Connected insulin pen injection data

Primary result

As reported in the abstract

Basal insulin adherence

Weekly averaged overall adherence levels

70.6 % to 79.3 %

Participants with deviation from recommended dose, primarily increased or reduced doses

98.8 %

Further findings

OutcomeOR (95 % CI)
Characteristics of non-adherent vs adherent participantsNon-adherent vs Adherent · HbA1c; higher in non-adherent0.96 (0.93–0.99)
Characteristics of non-adherent vs adherent participantsNon-adherent vs Adherent · total daily insulin dose; higher in non-adherent0.99 (0.98–0.99)
Characteristics of non-adherent vs adherent participantsNon-adherent vs Adherent · physical activity; lower in non-adherent2.55 (1.23–5.28)

Original publication

Assessment of basal insulin adherence in people with type 2 diabetes in telemonitoring: Post-hoc analysis of novel data modalities including insulin injection data. Diabetes Res Clin Pract. Published 17 April 2025. doi:10.1016/j.diabres.2025.112191

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.